Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Care Management: Cultural Competence and the Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ) Patient
This article originally appeared CareManagement, and is reprinted here with permission.
Workers' Comp
Article
10 Things You Need To Know About California SB 1160
This includes provisions to eliminate utilization review (UR) delays and inappropriate denials of care for injured workers, as well as prevent bill
Workers' Comp
Case Study
American Airlines: How Customization and Collaboration Resulted in Improved Return to Work and Significant Savings
"Genex held an important role in the workers’ compensation program creation and directly contributed to achieving our goals.
Workers' Comp
News Release
Genex Services Expands IME Services Through ECN Acquisition
National company extends Genex IME platform for non-occupational disability and automobile insurance markets WAYNE, PA - January
PDF
News Release
Press Release - Coventry Acrometis Partnership
Workers' Comp
News Release
Coventry and Acrometis Form Data-and-Technology Partnership to Drive Efficiency
DOWNERS GROVE, Ill. (Jan.